Go to contentGo to menuGo to searchGo to the news list

MitoVasc : physiopathologie cardiovasculaire et mitochondriale

Main navigation



    Equipe 2 -CarMe - 2019

    Equipe 2 -CarMe - 2019

    • Share this page on social networks
    • E-mail this page

      Send by mail

      Separated by coma
    • Print this page
    • 1. Back M, et al. Endogenous Calcification Inhibitors in the Prevention of Vascular Calcification: A Consensus Statement From the COST Action EuroSoftCalcNet. Front Cardiovasc Med. 2018;5:196.
    • 2. Abraham P, et al. Validation of the clinical frailty score (CFS) in French language. BMC Geriatr. 2019;19:322.
    • 3. Abraham P, et al. Microcirculation study to determine the anaerobic threshold during exercise. Clin Biomech (Bristol, Avon). 2019;70:80.
    • 4. Agard C, et al. Giant cell arteritis-related aortitis with positive or negative temporal artery biopsy: a French multicentre study. Scand J Rheumatol. 2019;48:474-481.
    • 5. Alijotas-Reig J, et al. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry. Rheumatology (Oxford). 2019.
    • 6. Alijotas-Reig J, et al. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. Autoimmun Rev. 2019;18:406-414.
    • 7. Ammi M, et al. Lower Rate of Restenosis and Reinterventions With Covered vs Bare Metal Stents Following Innominate Artery Stenting. J Endovasc Ther. 2019;26:385-390.
    • 8. Behaghel V, et al. Remote Ischemic Conditioning in a Model of Severe Renal Ischemia-Reperfusion Injury. Shock. 2019;51:795-799.
    • 9. Beloncle F, et al. Determinants of Doppler-based renal resistive index in patients with septic shock: impact of hemodynamic parameters, acute kidney injury and predisposing factors. Ann Intensive Care. 2019;9:51.
    • 10. Berthin C, et al. Dermoscopic phenotype of pseudoxanthoma elasticum skin lesions: a study of 16 patients. J Eur Acad Dermatol Venereol. 2019;33:e262-e265.
    • 11. Bouderlique E, et al. Vitamin D and Calcium Supplementation Accelerates Randall's Plaque Formation in a Murine Model. Am J Pathol. 2019;189:2171-2180.
    • 12. Brzhozovskiy AG, et al. The Effects of Spaceflight Factors on the Human Plasma Proteome, Including Both Real Space Missions and Ground-Based Experiments. Int J Mol Sci. 2019;20.
    • 13. Chassain K, et al. [Nagashima-type palmoplantar keratoderma: A little-known palmoplantar keratoderma in Europe]. Ann Dermatol Venereol. 2019;146:125-130.
    • 14. Chennupati R, et al. Myogenic vasoconstriction requires G12/G13 and LARG to maintain local and systemic vascular resistance. Elife. 2019;8.
    • 15. Commereuc M, et al. Hyperchloremia is not associated with AKI or death in septic shock patients: results of a post hoc analysis of the "HYPER2S" trial. Ann Intensive Care. 2019;9:95.
    • 16. Congnard F, et al. Simulator-based assessment of ankle arterial systolic blood pressure measurement skills. Blood Press Monit. 2019;24:306-309.
    • 17. Constans J, et al. Urgent need to clarify the definition of chronic critical limb ischemia - a position paper from the European Society for Vascular Medicine. Vasa. 2019;48:223-227.
    • 18. Datzmann T, et al. Cardiac Effects of Hyperoxia During Resuscitation From Hemorrhagic Shock in Swine. Shock. 2019;52:e52-e59.
    • 19. Desquiret-Dumas V, et al. Warburg-like effect is a hallmark of complex I assembly defects. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2475-2489.
    • 20. Dieu X, et al. Apparent resistance to thyroid hormones: From biological interference to genetics. Ann Endocrinol (Paris). 2019;80:280-285.
    • 21. Duplay Q, et al. Can postoperative calcemia kinetics predict the risk of hypocalcemia for the management of parathyroid adenoma in ambulatory surgery? J Visc Surg. 2019.
    • 22. Duret-Aupy N, et al. Liver sinusoidal obstruction syndrome associated with trastuzumab emtansine treatment for breast cancer. Therapie. 2019;74:675-677.
    • 23. Frangieh J, et al. First Characterization of The Venom from Apis mellifera syriaca, A Honeybee from The Middle East Region. Toxins (Basel). 2019;11.
    • 24. Garcia G, et al. Metabolomic Approach in STEMI-Patients Undergoing Left Ventricular Remodeling. Int J Mol Sci. 2019;20.
    • 25. Gourronc Y, et al. De novo atrial fibrillation as an independent prognostic marker after ST-segment elevation myocardial infarction: Results from the RIMA registry. J Cardiol. 2019;74:123-129.
    • 26. Goyer B, et al. Impact of ultraviolet radiation on dermal and epidermal DNA damage in a human pigmented bilayered skin substitute. J Tissue Eng Regen Med. 2019;13:2300-2311.
    • 27. Guerrero-Aspizua S, et al. Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients. Orphanet J Rare Dis. 2019;14:183.
    • 28. Guillou S, et al. Direct Rivaroxaban-Induced Factor Xa Inhibition Proves to be Cardioprotective in Rats. Shock. 2019.
    • 29. Henni S, et al. Treadmill Measured vs. Questionnaire Estimated Changes in Walking Ability in Patients With Peripheral Artery Disease. Eur J Vasc Endovasc Surg. 2019;57:676-684.
    • 30. Henni S, et al. High prevalence of exercise-induced ischemia in the asymptomatic limb of patients with apparently strictly unilateral symptoms and unilateral peripheral artery disease. Ther Adv Cardiovasc Dis. 2019;13:1753944718819063.
    • 31. Henni S, et al. Microvascular Response to the Roos Test Has Excellent Feasibility and Good Reliability in Patients With Suspected Thoracic Outlet Syndrome. Front Physiol. 2019;10:136.
    • 32. Henni S, et al. A new electron paramagnetic resonance device to measure transcutaneous oxygen in humans. Magn Reson Med. 2019;81:2835-2836.
    • 33. Henni S, et al. Painless local pressure application to test microvascular reactivity to ischemia. Microvasc Res. 2019;122:13-21.
    • 34. Hersant J, et al. We all dream of simple things. Prim Care Diabetes. 2019.
    • 35. Hersant J, et al. Screening for peripheral artery disease in people with diabetes. Diabet Med. 2019;36:256-257.
    • 36. Hersant J, et al. Tyrosine kinase inhibitor-induced carotid stenosis: A case report. Leuk Res Rep. 2019;12:100171.
    • 37. Hersant J, et al. A pilot study of forearm microvascular impairment and pain while using a telephone. Microvasc Res. 2019;129:103963.
    • 38. Javaud N, et al. Hereditary angioedema, emergency management of attacks by a call center. Eur J Intern Med. 2019;67:42-46.
    • 39. Javaud N, et al. Hereditary angioedema: Clinical presentation and socioeconomic cost of 200 French patients. J Allergy Clin Immunol Pract. 2019;7:328-330.
    • 40. Javaud N, et al. Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial. BMJ Open. 2019;9:e027431.
    • 41. Jouan Y, et al. Effects of mean arterial pressure on arousal in sedated ventilated patients with septic shock: a SEPSISPAM post hoc exploratory study. Ann Intensive Care. 2019;9:54.
    • 42. Kermorgant M, et al. Effects of Resistance Exercise and Nutritional Supplementation on Dynamic Cerebral Autoregulation in Head-Down Bed Rest. Front Physiol. 2019;10:1114.
    • 43. Lascarrou JB, et al. Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm. N Engl J Med. 2019;381:2327-2337.
    • 44. Laterre PF, et al. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial. JAMA. 2019.
    • 45. Leclerc-Mercier S, et al. Cutaneous granulomas with primary immunodeficiency in children: a report of 17 new patients and a review of the literature. J Eur Acad Dermatol Venereol. 2019;33:1412-1420.
    • 46. Leducq S, et al. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial. Trials. 2019;20:739.
    • 47. Leducq S, et al. Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area. Eur J Dermatol. 2019;29:82-83.
    • 48. Legoute F, et al. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial. Radiat Oncol. 2019;14:83.
    • 49. Letavernier E, et al. Pseudoxanthoma Elasticum, Kidney Stones and Pyrophosphate: From a Rare Disease to Urolithiasis and Vascular Calcifications. Int J Mol Sci. 2019;20.
    • 50. Levy M, et al. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol. 2019.
    • 51. Lhomme A, et al. Stretch-activated Piezo1 Channel in Endothelial Cells Relaxes Mouse Intrapulmonary Arteries. Am J Respir Cell Mol Biol. 2019;60:650-658.
    • 52. Madonna R, et al. ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure. Cardiovasc Res. 2019;115:488-500.
    • 53. Martin L, Granry JC. [On the practice and uses of simulation in dermatology]. Ann Dermatol Venereol. 2019;146:343-345.
    • 54. Martin-Loeches I, et al. Influenza and associated co-infections in critically ill immunosuppressed patients. Crit Care. 2019;23:152.
    • 55. Mattei C, et al. Involvement of the GABAA receptor alpha subunit in the mode of action of etifoxine. Pharmacol Res. 2019;145:104250.
    • 56. Mezdad T, et al. Identification of new factors associated to walking impairment in patients with vascular-type claudication. Vascular. 2019;27:260-269.
    • 57. Miailhe AF, et al. Severe leptospirosis in non-tropical areas: a nationwide, multicentre, retrospective study in French ICUs. Intensive Care Med. 2019;45:1763-1773.
    • 58. Mirallie E, et al. Adrenocortical carcinoma: Impact of surgical treatment. Ann Endocrinol (Paris). 2019;80:308-313.
    • 59. Navasiolava N, et al. The extent of pseudoxanthoma elasticum skin changes is related to cardiovascular complications and visual loss: a cross-sectional study. Br J Dermatol. 2019;180:207-208.
    • 60. Omarjee L, et al. Internal Carotid Artery Hypoplasia: A New Clinical Feature in Pseudoxanthoma Elasticum. J Stroke. 2019;21:108-111.
    • 61. Omarjee L, et al. Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL study. Vascul Pharmacol. 2019;118-119:106563.
    • 62. Omarjee L, et al. Severe early-onset manifestations of pseudoxanthoma elasticum resulting from the cumulative effects of several deleterious mutations in ENPP1, ABCC6 and HBB: transient improvement in ectopic calcification with sodium thiosulfate. Br J Dermatol. 2019.
    • 63. Omarjee L, et al. Evidence of Cardiovascular Calcification and Fibrosis in Pseudoxanthoma Elasticum Mouse Models Subjected to DOCA-Salt Hypertension. Sci Rep. 2019;9:16327.
    • 64. Parker VER, et al. Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum. Genet Med. 2019;21:1189-1198.
    • 65. Pautu V, et al. Melanoma tumour vasculature heterogeneity: from mice models to human. J Cancer Res Clin Oncol. 2019;145:589-597.
    • 66. Phan C, et al. Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis. J Eur Acad Dermatol Venereol. 2019;33:1984-1992.
    • 67. Pipelart V, et al. A study of optic nerve head drusen in 38 pseudoxanthoma elasticum (PXE) patients (64 eyes). Location of optic nerve head drusen in PXE. J Fr Ophtalmol. 2019;42:262-268.
    • 68. Pomozi V, et al. Dietary Pyrophosphate Modulates Calcification in a Mouse Model of Pseudoxanthoma Elasticum: Implication for Treatment of Patients. J Invest Dermatol. 2019;139:1082-1088.
    • 69. Roubille F, et al. Effects of remote ischemic conditioning on kidney injury in at-risk patients undergoing elective coronary angiography (PREPARE study): a multicenter, randomized clinical trial. Sci Rep. 2019;9:11985.
    • 70. Sarre ME, et al. Association between serum 25-hydroxyvitamin D concentration and severity of first-diagnosed bullous pemphigoid in older adults. Arch Gerontol Geriatr. 2019;83:28-30.
    • 71. Scheeren TWL, et al. Current use of vasopressors in septic shock. Ann Intensive Care. 2019;9:20.
    • 72. Sempore WY, et al. The walking estimated limitation stated by history (WELSH): a visual tool to self-reported walking impairment in a predominantly illiterate population. Cardiovasc J Afr. 2019;30:1-6.
    • 73. Trzepizur W, et al. Obstructive sleep apnoea severity and liver steatosis measured by magnetic resonance imaging. Eur Respir J. 2019.
    • 74. Udry S, et al. A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome. Immunol Res. 2019.
    • 75. Walkey AJ, et al. Mediation Analysis of High Blood Pressure Targets, Arrhythmias, and Shock Mortality. Am J Respir Crit Care Med. 2019;199:802-805.
    • 76. Yuan M, et al. Multi-System Adaptation to Confinement During the 180-Day Controlled Ecological Life Support System (CELSS) Experiment. Front Physiol. 2019;10:575.
    • 77. Yvin E, et al. [Chronic superficial urticaria associated with solid cancers: Case report and literature review]. Ann Dermatol Venereol. 2019;146:377-381.
    • 78. Zanoli L, et al. Arterial Stiffness in the Heart Disease of CKD. J Am Soc Nephrol. 2019;30:918-928.